Dupuytren's Contracture
Dupuytren's contracture is a condition where the connective tissue in the palm thickens and tightens, gradually pulling one or more fingers (most often the ring and little fingers) toward the palm and limiting the ability to fully straighten them. A hand specialist evaluation determines severity and appropriate treatment; shockwave therapy has been studied in small, early trials, generally as a way to address pain and some functional symptoms rather than to reverse established contracture.
Common Symptoms
- A firm nodule or cord of tissue in the palm, often near the base of the ring or little finger
- Gradual inability to fully straighten one or more fingers
- Tenderness in the nodule, particularly earlier in the condition
- Difficulty with tasks requiring a flat hand, such as putting on gloves or shaking hands fully
Why It Happens
The connective tissue layer beneath the skin of the palm (the palmar fascia) thickens and contracts for reasons that aren't fully understood, though genetics play a significant role — it's more common in people of Northern European descent and often runs in families. It's also associated with diabetes, smoking, and certain other conditions.
Why It Can Become Persistent
Once the connective tissue has contracted, it generally doesn't loosen back up on its own — this is a structural, progressive change in the tissue itself, which is why established contracture typically needs a targeted procedure rather than time or exercise alone to improve.
Who Commonly Gets It
Dupuytren's contracture is most common in men over 40 of Northern European ancestry, and tends to run in families.
How It Is Usually Diagnosed
Diagnosis is clinical, based on the characteristic nodules and cords in the palm and the pattern of finger contracture. A hand specialist can assess severity and monitor progression over time.
Traditional Treatment Options
- Observation: For mild, non-progressive cases without significant functional limitation, monitoring is often appropriate.
- Needle aponeurotomy: A minimally invasive procedure to release the contracted cord using a needle, for appropriate candidates.
- Enzyme injection (collagenase): An FDA-approved injectable option that breaks down the contracted cord for qualifying cases.
- Surgical fasciectomy: Removal of the affected tissue, generally reserved for more significant or recurrent contracture.
Why Someone Might Start Looking for Another Option
Because established treatments for Dupuytren's are procedural (needle release, enzyme injection, or surgery), people with earlier-stage disease — nodules, tenderness, or mild contracture — sometimes look for non-invasive options to address symptoms, which is where shockwave therapy research comes in.
Where Shockwave Therapy May Fit
The evidence here is early and comes from small studies: a pilot study comparing radial and focused shockwave therapy found both reduced pain and improved function, with radial shockwave showing an edge for pain reduction and focused shockwave showing an edge for reducing nodule size; a separate small, uncontrolled study found continued improvement in pain and finger contraction angles over 14 weeks. We want to be direct that these are small, early-stage studies (one without a control group) — this is not established treatment for reversing established contracture, and the enzyme injection and procedural options above remain the primary evidence-based treatments for functionally significant contracture.
How Shockwave Treatment Works for This Area
If considered appropriate after evaluation by a hand specialist, shockwave therapy would be applied to the affected palmar tissue — this would be discussed as an early-stage, symptom-focused option, not a substitute for procedural treatment when contracture is already functionally significant.
What the Treatment Feels Like
Most patients describe a firm tapping or pressure sensation directly over the nodule or cord in the palm; your provider will discuss what to expect.
What Happens During Your First Visit
Your visit begins with a provider evaluation focused on your history and a physical exam relevant to your complaint. If shockwave therapy is determined to be clinically appropriate, your first treatment can typically be provided the same visit. See our What to Expect page for the full walkthrough.
New Patient Offer
New Patient Exam + First Treatment — $99
First treatment provided when clinically appropriate following your examination.
Who May Not Be Appropriate
- Anyone who has not yet had a hand specialist evaluation, particularly with functionally significant contracture
- Anyone seeking this as an alternative to needle aponeurotomy, enzyme injection, or surgery for established, functionally limiting contracture
- Active infection or open wounds at the treatment site
This list is not exhaustive. Your provider will screen for contraindications during your evaluation.
Frequently Asked Questions
The current evidence doesn't support that — it comes from small, early studies looking mainly at pain and some functional measures, not reliable correction of established contracture. Needle aponeurotomy, enzyme injection, and surgery remain the established options for meaningful correction.
No — they're different conditions. Trigger finger involves a tendon catching in its pulley; Dupuytren's contracture involves thickening of the connective tissue layer in the palm itself, gradually pulling the finger toward the palm. They can occasionally occur in the same hand.
What Research Says
Selected sources relevant to dupuytren's contracture. See the full Research Center for our complete source registry and methodology.
Archives of Health Science and Research · 2025 · Tezen, Ata, Yılmaz, Uzun, Yaşar
This pilot study of 22 patients with Dupuytren's contracture compared radial and focused shockwave therapy (both alongside a home tendon-gliding exercise program) and found both approaches significantly reduced pain and improved function; radial shockwave produced significantly greater pain reduction, while focused shockwave produced significantly greater reduction in nodule size. Neither approach significantly improved grip strength.
Limitations: Very small sample (22 patients), no sham or no-treatment control group, and only a 3-week treatment period — placebo and natural-history effects can't be ruled out. A published critique/response exchange exists in the same journal about this study's methodology, which we were not able to fully review.
Advanced Biomedical Research · 2022 · Taheri, Salek, Mousavi, Maghroori
This uncontrolled study of 20 patients with Dupuytren's contracture found pain, disability, and finger contraction angle continued to improve significantly through 14 weeks of follow-up after 6 weekly shockwave therapy sessions.
Limitations: No control group — without a comparison group, natural fluctuation or placebo response can't be ruled out — and a small sample (20 patients) with follow-up limited to 14 weeks, so durability beyond that point isn't established.
Related Conditions
Related Treatment Options
Schedule Now in Palatine
First treatment provided when clinically appropriate following your examination.
